SCICLONE PHARMACEUTICALS INC: accounts_receivable
| Value | {"amount": 41763000, "concept": "us-gaap:AccountsReceivableNetCurrent", "currency": "USD"} |
|---|---|
| Period | (as of 2012-06-30) |
| Status | superseded |
| Entity | SCICLONE PHARMACEUTICALS INC |
Provenance
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
Retrieved: 2026-08-19T08:47:37.333294+02:00
Raw response sha256:
Also addressable by official identifiers:
Cite as: FACTANKER, https://factanker.com/fact/0bc6bbe3-ff34-48aa-a553-aa51df30c6b6
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
0001193125-12-344360Retrieved: 2026-08-19T08:47:37.333294+02:00
Raw response sha256:
f7bde1a401b286c74a2fd824ee1df541…Also addressable by official identifiers:
https://factanker.com/fact/sec/cik-0000880771/accounts-receivable/2012-06-30 (CIK, metric, reporting date)Cite as: FACTANKER, https://factanker.com/fact/0bc6bbe3-ff34-48aa-a553-aa51df30c6b6
History
- no predecessors — first report